| Name | Canrenone |
|---|---|
| Synonyms |
lerenone IMpurity - Canrenone
CANRENONE sc9376 17-Hydroxy-3-oxo-17-pregna-4,6-diene-21-cboxylicacid-lactone Phanurane 4,6-ANDROSTEN-17-ALPHA-YL-PROPIONIOACID-R-LACTONE ALDADIENE 11614r.p 3-(3-Oxo-17b-hydroxy-4,6-androstadien-17a-yl)propionic Acid g-Lactone CANRENONE-D4 PREGNA-4,6-DIENE-17-BETA-0L-3-ONE-21-CBOXYLIC ACID-GAMMA LACTONE 7-Cboxy-9Δ-canrenone phanurane Canrenone Solution, 100ppm Spironolactone Related CoMpound A CANRENOIC ACID GAMMA LACTONE Canrenone D7Q: What is Canrenone D7 Q: What is the CAS Number of Canrenone D7 Q: What is the storage condition of Canrenone D7 Q: What e the applications of Canrenone D7 Journal of risperidone Canrenone 17-hydroxy-3-oxo-17a-pregna-4,6-diene-21-cboxylic acid gamma-lactone CANRENONE[SPIRONOLACTONE INTERMEDIATE] Pregna-4,6-diene-21-cboxylic acid, 17-hydroxy-3-oxo-, γ-lactone, (17α) spirolactonesc14266 Luvion lerenone Impurity 28 10,13-Dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione Spironolactone Impurity F 17-hydroxy-3-oxo-17a-pregna-4,6-diene-21-cboxylic acid gamma-lactone CanrenoneMin CanrenoneQ: What is Canrenone Q: What is the CAS Number of Canrenone Q: What is the storage condition of Canrenone Q: What e the applications of Canrenone 17-hydroxy-3-oxo-,gamma-lactone,(17-alpha)-pregna-6-diene-21-cboxylicacid Candy, ketone (-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid -Lactone) Spironolactone Impurity F (Canrenone) Spironolactone Impurity F-d4 (Canrenone-d4) Spironolactone Impurity 6(Spironolactone Impurity F) Canrenone CRS 17-(2-Cboxyethyl)17-hydroxyandrosta-4,6-dien-3-onelactone 6,7-Dehydro-7α-desthioacetylspironolactone (17α)-17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylicacidγ-lactone RP-11614 pregna-4,6-diene-21-cboxylicacid,17-hydroxy-3-oxo-,gamma-lactone,(17-alph Canrenone, >= Spiranolactone Impurity F (8R,9S,10R,13S,14S,17R)-10,13-Dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione 11614 R.P. 7-Cboxy-9&Delta (17R)-3-Oxo-17-hydroxypregna-4,6-diene-21-cboxylic acid γ-lactone Pregna-4,6-diene-21-cboxylicacid, 17-hydroxy-3-oxo-, g-lactone, (17a) (17a)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid g-lactone 17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one Lactone 17a-(2-Carboxyethyl)-17b-hydroxy-3-oxoandrosta-4,6-diene Lactone kanlitong Contaren 6-Dehydrotestosterone-17a-propionic Acid g-Lactone lerenone Canrenone Impurity (7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid -Lactone 4,6-ANDROSTADIEN[(17(B-1')-SPIRO-5')]-PERHYDROFURAN-2,3-DIONE (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione 17a-(2-Cboxyethyl-17b-hydroxyandrosta-4,6-dien-3-one Lactone 17-(2-Cboxyethyl)17-hydroxy-3-oxoandrosta-4,6-dienelactone (17R)-17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylic acid γ-lactone Spironolactone Related Compound A (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-cbolactone)) 17a-2-Cboxyethyl-17-hydroxyandrosta-4,6-dien-3-one Lactone Spironolactone Related Compound A (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-cbolactone)) (AS) (7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid g-Lactone |
| Description | Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent. |
|---|---|
| Related Catalog | |
| Target |
Target: Aldosterone[1] |
| In Vitro | Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner[1]. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na+/H+ exchanger 1 induced by platelet-derived growth factor[2]. |
| In Vivo | Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone[3]. |
| Cell Assay | Confluent Hepatic Stellate Cells (HSC) are incubated in SFIF medium for 24 hours and exposed to increasing concentrations of canrenone (1, 5, 10, 25 μM). Cell viability is evaluated by the trypan blue dye exclusion test at the end of a 24- to 48-hour incubation period[2]. |
| Animal Admin | Rats[3] Canrenone (CAN) is given orally in two different doses (10.25, 20.5 mg/mL) to Male SPF Sprague-Dawley rats for 6 weeks. To determine the Na+, K+, fluid and aldosterone excretion the urine of the rats destined to be killed after 6 weeks is collected at weekly intervals[3]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 541.1±50.0 °C at 760 mmHg |
| Melting Point | 158-160ºC |
| Molecular Formula | C22H28O3 |
| Molecular Weight | 340.456 |
| Flash Point | 237.6±30.2 °C |
| Exact Mass | 340.203857 |
| PSA | 43.37000 |
| LogP | 2.99 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.581 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H351-H411 |
| Precautionary Statements | P280 |
| Hazard Codes | Xn,N |
| Risk Phrases | 40-51/53 |
| Safety Phrases | 36/37-61 |
| RIDADR | UN 3077 9 / PGIII |
| HS Code | 29329990 |
| Precursor 7 | |
|---|---|
| DownStream 6 | |